Form 4: Unity Biotechnology CFO Lynne Sullivan Reports Acquisition of Shares and Stock Options

Lynne Marie Sullivan, CFO of Unity Biotechnology, reports the acquisition of 65,000 shares of common stock and options to purchase 106,000 shares following the satisfaction of performance criteria.

Summary

• Lynne Marie Sullivan, the CFO and Head of Corporate Development at Unity Biotechnology, filed a Form 4 on March 31, 2025.
• The report details transactions related to Unity Biotechnology's common stock and stock options.
• On March 28, 2025, Sullivan acquired 65,000 shares of common stock as Restricted Stock Units (RSUs) that vested upon meeting certain performance criteria.
• Sullivan also acquired options to purchase 106,000 shares of common stock on March 28, 2025, with half vesting upon meeting performance criteria and the remainder vesting in monthly installments.
• Following these transactions, Sullivan beneficially owns 120,772 shares of common stock and options for 106,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The vesting of RSUs and options indicates that performance criteria were met, which is a positive sign. However, it's a routine disclosure and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The vesting of RSUs and stock options suggests that performance criteria were met, which could be viewed positively.
• Increased ownership by a key executive can signal confidence in the company's future prospects.

Future Outlook

The remaining half of the stock options will vest in 12 successive, equal monthly installments, subject to continued service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• Shareholders may view the increased ownership by a key executive as a positive signal.
• Employees may be motivated by the achievement of performance criteria that led to the vesting of RSUs and options.

Key Dates

Keywords

Unity Biotechnology, UBX, Lynne Sullivan, CFO, Form 4, Stock Options, Restricted Stock Units, Beneficial Ownership, Insider Trading